Blood transfusion triggers mouse ageing

0
US researchers have reported that receiving a single blood transfusion from old mice caused the ageing of tissue in young mice. But treatment of...

$25 million settlement for breast augmentation class-action lawsuit

0
A multimillion-dollar settlement has been proposed in a class-action lawsuit against The Cosmetic Institute. Women in NSW and Qld who claim to have suffered...

COSMEDICON 2024 Highlights

0
Aesthetic Medical Practitioner Magazine’s 7th annual COSMEDICON secured its position as Australia’s premier boutique aesthetic medicine conference. Aesthetic Medical Practitioner (AMP) magazine once again came...
cosmetic surgery hotline

Cosmetic surgery industry under scrutiny as Ahpra closes 200th case

0
In an unwavering crackdown on cosmetic surgery malpractices, the Australian Health Practitioner Regulation Agency (Ahpra) has announced the completion of its 200th cosmetic surgery...

US women live 5.8 years longer

0
New data from the US National Centre for Health Statistics (NCHS) has revealed the life expectancy gap between American men and women has widened...

FDA approves new obesity drug Zepbound

0
The US Food and Drug Administration (FDA) has approved Eli Lilly’s new obesity treatment Zepbound (tirzepatide) for ‘chronic weight management in adults who are...
court rules in favour of new cosmetic surgery guidelines

Plastic surgeons lose legal bid to overturn new MBA guidelines

0
Plastic surgeons Dr Peter Callan and Dr Simone Matousek have lost their case to overturn new industry guidelines by Ahpra and the Medical Board...
podiatric surgeons in australia may lose title of 'surgeon'

Title change for podiatric surgeons: Ahpra

0
Podiatrists who perform procedures could no longer be allowed to use the title of ‘podiatric surgeon’, under recommendations from the Independent review of the...
weight loss pill amycretin: initial results promising

New weight-loss pill amycretin outperforms semaglutide in early trial

0
In yet another addition to the skyrocketing weight-loss drug market, amycretin is sparking attention among researchers and the medical community due to its potential...
rare risk of botulism after botulinum toxin injections

Botulism after botulinum toxin: case report

0
A new case report published in Cureus* highlights the importance of recognising and treating iatrogenic botulism. Although iatrogenic botulism is rare, it is a...

POPULAR POSTS